Millipore Sigma Vibrant Logo

532384 PI3K Inhibitor, HS-173 - Calbiochem

PI3 K alpha inhibitor; anti-fibrolytic agent; HS-173

PI3K Inhibitor, HS-173 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: PI3Kα Inhibitor, Phosphatidylinositol 3-kinase α Inhibitor

Primary Target: PI3Ka
View This Product on Sigma-Aldrich
532384
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
1276110-06-5C₂₁H₁₈N₄O₄S

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
5.32384.0001
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 ｶﾞﾗｽﾋﾞﾝ 10 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell permeable imidazopyridine-carboxylate derived compound that acts as a potent and selective inhibitor of phosphatidylinositol 3-kinase a (PI3Ka; IC50 = 800 pM). Blocks the proliferation of several cancer cells (IC50 = 600 nM; 1.5 µM, and 7.8 µM for T47D, SK-BR3, and MCF-7 cells, respectively). Suppresses the growth and proliferation of hepatic stellate cells (HSC-T6 and LX-2 cells) and induces cell cycle arrest at G2/M phase in a dose and time-dependent manner. Induces apoptosis in HSC-T6 cells (~5 µM) as evidenced by morphological changes, activation of caspase-3, reduction in Bcl-2 levels, and loss of mitochondrial transmembrane potential. Exhibits anti-fibrolytic activity and diminishes the expression of profibrotic mediators, such as fibronectin and vimentin (~ 1 µM) and weakens the severity of hepatic damage in a murine model of carbon tetrachloride-induced fibrosis and reduces the phosphorylation of Akt and p70S6 kinase (10 mg/kg, p.o., 6d/week for 1 month).

      Please note that the molecular weight for this compound is batch-specific due to variable water content.
      Catalogue Number532384
      Brand Family Calbiochem®
      SynonymsPI3Kα Inhibitor, Phosphatidylinositol 3-kinase α Inhibitor
      References
      ReferencesSon, M.K., et al. 2013. Sci. Rep. 3, 3470.
      Lee, H., et al. 2013. Onc. Rep. 30, 863.
      Kim, O., et al. 2011. J. Med. Chem. 54, 2455.
      Product Information
      CAS number1276110-06-5
      FormLight beige powder
      Hill FormulaC₂₁H₁₈N₄O₄S
      Chemical formulaC₂₁H₁₈N₄O₄S
      ReversibleY
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPI3Ka
      Primary Target IC<sub>50</sub>800 pM
      Purity≥96% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      5.32384.0001 04055977287226

      Documentation

      PI3K Inhibitor, HS-173 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      参考資料

      参考資料の概要
      Son, M.K., et al. 2013. Sci. Rep. 3, 3470.
      Lee, H., et al. 2013. Onc. Rep. 30, 863.
      Kim, O., et al. 2011. J. Med. Chem. 54, 2455.

      技術情報

      タイトル
      White Paper: Further considerations of antibody validation and usage.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-February-2015 JSW
      SynonymsPI3Kα Inhibitor, Phosphatidylinositol 3-kinase α Inhibitor
      DescriptionA cell permeable imidazopyridine-carboxylate derived compound that acts as a potent and selective inhibitor of phosphatidylinositol 3-kinase a (PI3Ka; IC50 = 800 pM). Blocks the proliferation of several cancer cells (IC50 = 600 nM; 1.5 µM, and 7.8 µM for T47D, SK-BR3, and MCF-7 cells, respectively). Suppresses the growth and proliferation of hepatic stellate cells (HSC-T6 and LX-2 cells) and induces cell cycle arrest at G2/M phase in a dose and time-dependent manner. Induces apoptosis in HSC-T6 cells (~5 µM) as evidenced by morphological changes, activation of caspase-3, reduction in Bcl-2 levels, and loss of mitochondrial transmembrane potential. Exhibits anti-fibrolytic activity and diminishes the expression of profibrotic mediators, such as fibronectin and vimentin (~ 1 µM) and weakens the severity of hepatic damage in a murine model of carbon tetrachloride-induced fibrosis and reduces the phosphorylation of Akt and p70S6 kinase (10 mg/kg, p.o., 6d/week for 1 month).
      FormLight beige powder
      Intert gas (Yes/No) Packaged under inert gas
      CAS number1276110-06-5
      Chemical formulaC₂₁H₁₈N₄O₄S
      Purity≥96% by HPLC
      SolubilityDMSO (50 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesSon, M.K., et al. 2013. Sci. Rep. 3, 3470.
      Lee, H., et al. 2013. Onc. Rep. 30, 863.
      Kim, O., et al. 2011. J. Med. Chem. 54, 2455.